Top compounds associated with response to CABP4


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.01
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.02
mRNA VX-680 GDSC1000 pan-cancer AAC -0.13 0.02
mRNA necrostatin-7 CTRPv2 pan-cancer AAC 0.089 0.02
mRNA Crizotinib gCSI pan-cancer AAC -0.13 0.02
mRNA MLN4924 GDSC1000 pan-cancer AAC -0.092 0.02
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.11 0.02
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
mRNA YM-155 GDSC1000 pan-cancer AAC -0.08 0.02
Download CSV